Bioasis

A proprietary peptide based delivery platform for developing CNS drugs which can cross the blood-brain barrier

placeNew York City, New York, United States calendar_todayFounded 2007 groups7 employees language bioasis.us

Registered entities

Investor mix

2 investors on record; 1 has since exited.

Investor typeCountShare
Private equity150%
Accelerator & incubator150%
Coming soon